Small Molecules Blog

Opportunities and Perspectives on the Design and Synthesis of PROTAC® Degraders

Somatic Instability and Huntington's Disease

Development of a KRAS-Targeting PROTAC

Development of a KRAS Targeting PROTAC Banner


In this question-and-answer session, Michael Bond (Yale University) talks to our Senior Product Specialist, Alex Moloney PhD, about the development of LC 2, a KRAS G12C-targeting PROTAC® which is now available from Tocris.

Regenerative Medicine - From Bench to Clinic

SARS-CoV-2: An Update on Key Targets, Trends and Discoveries

Existing Drugs Targeting SARS-CoV-2 and Coronaviruses

Existing Drugs Targeting SARS-CoV-2 and Coronaviruses

All Tocris products mentioned in this blog post are for biomedical research use only. They are not intended for human or veterinary use.

ROCK Inhibitor for Stem Cell Cryopreservation

Celebrating 25 Years of Tocris Cookson

Targeting the Immune System in Cancer with Small Molecules

Five Reasons to use Small Molecules in Stem Cell Research